E3 Ubiquitin Ligases in Endothelial Dysfunction and Vascular Diseases: Roles and Potential Therapies
暂无分享,去创建一个
M. Fu | H. Xin | Xuan Huang | Yisong Qian | Yihan Wang | Yixiong Zhan | Linsiqi Wang
[1] Zhengyan Liang,et al. A Comprehensive Analysis Revealing FBXW9 as a Potential Prognostic and Immunological Biomarker in Breast Cancer , 2023, International journal of molecular sciences.
[2] A. Leichtle,et al. TRIM21 Expression as a Prognostic Biomarker for Progression-Free Survival in HNSCC , 2023, International journal of molecular sciences.
[3] D. Kotton,et al. Novel FOXF1-Stabilizing Compound TanFe Stimulates Lung Angiogenesis in Alveolar Capillary Dysplasia. , 2022, American journal of respiratory and critical care medicine.
[4] U. Pendurthi,et al. Gab2-MALT1 Axis Regulates Thromboinflammation and Deep Vein Thrombosis. , 2022, Blood.
[5] D. Baptista,et al. The E3 Ubiquitin Ligase Peli1 Deficiency Promotes Atherosclerosis Progression , 2022, Cells.
[6] M. Fu,et al. TRIM47 is a novel endothelial activation factor that aggravates lipopolysaccharide-induced acute lung injury in mice via K63-linked ubiquitination of TRAF2 , 2022, Signal Transduction and Targeted Therapy.
[7] Ji Cao,et al. MDM2-Mediated Ubiquitination of RXRβ Contributes to Mitochondrial Damage and Related Inflammation in Atherosclerosis , 2022, International journal of molecular sciences.
[8] W. Fang,et al. Liraglutide prevents high glucose induced HUVECs dysfunction via inhibition of PINK1/Parkin-dependent mitophagy , 2022, Molecular and Cellular Endocrinology.
[9] N. Maulik,et al. Gene therapy with Pellino-1 improves perfusion and decreases tissue loss in Flk-1 heterozygous mice but fails in MAPKAP Kinase-2 knockout murine hind limb ischemia model. , 2022, Microvascular research.
[10] Jingxin Gao,et al. E3 ubiquitin ligase mind bomb 1 overexpression reduces apoptosis and inflammation of cardiac microvascular endothelial cells in coronary microvascular dysfunction , 2021, Cellular Signalling.
[11] Meizi Yang,et al. Overexpression of E3 ubiquitin ligase Cbl attenuates endothelial dysfunction in diabetes mellitus by inhibiting the JAK2/STAT4 signaling and Runx3-mediated H3K4me3 , 2021, Journal of translational medicine.
[12] Wei He,et al. Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome , 2021, Acta Pharmaceutica Sinica B.
[13] Dan Chen,et al. E3 ubiquitin ligases: styles, structures and functions , 2021, Molecular Biomedicine.
[14] S. Wattanapitayakul,et al. Unripe Carica papaya Protects Methylglyoxal-Invoked Endothelial Cell Inflammation and Apoptosis via the Suppression of Oxidative Stress and Akt/MAPK/NF-κB Signals , 2021, Antioxidants.
[15] Jihong Han,et al. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies , 2021, Pharmacological Reviews.
[16] M. Rapé,et al. An E3 ligase guide to the galaxy of small-molecule-induced protein degradation. , 2021, Cell chemical biology.
[17] Yonghui Zhang,et al. The E3 Ubiquitin Ligase RNF5 Facilitates SARS-CoV-2 Membrane Protein-Mediated Virion Release , 2021, bioRxiv.
[18] Wei Jiang,et al. E3 ligase Nedd4l promotes antiviral innate immunity by catalyzing K29-linked cysteine ubiquitination of TRAF3 , 2021, Nature Communications.
[19] D. Stewart,et al. Endothelial cells in the pathogenesis of pulmonary arterial hypertension , 2021, European Respiratory Journal.
[20] I. Gregoric,et al. Endothelial Dysfunction and Its Clinical Implications , 2021, Angiology.
[21] M. Goumans,et al. Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence? , 2021, Biomedicines.
[22] E. Krüger,et al. The Ubiquitin–Proteasome System in Immune Cells , 2021, Biomolecules.
[23] T. Verano-Braga,et al. ACE2 in the renin-angiotensin system. , 2020, Clinical science.
[24] L. Claesson‐Welsh,et al. Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies. , 2020, Trends in molecular medicine.
[25] P. Moreira,et al. PINK1/PARKIN signalling in neurodegeneration and neuroinflammation , 2020, Acta neuropathologica communications.
[26] A. Ciulli,et al. E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones , 2020, SLAS discovery : advancing life sciences R & D.
[27] S. Orfanos,et al. Endothelial Damage in Acute Respiratory Distress Syndrome , 2020, International journal of molecular sciences.
[28] A. Zorzano,et al. The dialogue between the ubiquitin-proteasome system and autophagy: Implications in ageing , 2020, Ageing Research Reviews.
[29] F. Zhang,et al. Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms , 2020, Pharmacological Research.
[30] R. Kishore,et al. Potential role of hydrogen sulfide in diabetes-impaired angiogenesis and ischemic tissue repair , 2020, Redox biology.
[31] Liu Cao,et al. E3 Ubiquitin ligase NEDD4 family‑regulatory network in cardiovascular disease , 2020, International journal of biological sciences.
[32] P. Thistlethwaite,et al. MDM2-Mediated Ubiquitination of Angiotensin-Converting Enzyme 2 Contributes to the Development of Pulmonary Arterial Hypertension , 2020, Circulation.
[33] J. Garcia,et al. Targeting NOX4 alleviates sepsis-induced acute lung injury via attenuation of redox-sensitive activation of CaMKII/ERK1/2/MLCK and endothelial cell barrier dysfunction , 2020, Redox biology.
[34] Lin Li,et al. Pharmacological management of vascular endothelial dysfunction in diabetes: TCM and western medicine compared based on biomarkers and biochemical parameters. , 2020, Pharmacological research.
[35] Xiao-Jing Shi,et al. Skp2 in the ubiquitin-proteasome system: A comprehensive review. , 2020, Medicinal research reviews.
[36] G. Hummer,et al. Structural basis of ER-associated protein degradation mediated by the Hrd1 ubiquitin ligase complex , 2020, Science.
[37] D. Su,et al. HRD1 prevents atherosclerosis-mediated endothelial cell apoptosis by promoting LOX-1 degradation , 2020, Cell cycle.
[38] Yingxian Sun,et al. The E3 ubiquitin ligase Smurf2 regulates PARP1 stability to alleviate oxidative stress‐induced injury in human umbilical vein endothelial cells , 2020, Journal of cellular and molecular medicine.
[39] Zhi-wei Wang,et al. NEDD4 E3 ligase: Functions and mechanism in human cancer. , 2020, Seminars in cancer biology.
[40] Zhi-Sheng Jiang,et al. The Role of Ubiquitin E3 Ligase in Atherosclerosis. , 2020, Current medicinal chemistry.
[41] Fan Li,et al. APC/Cdh1 targets PECAM‐1 for ubiquitination and degradation in endothelial cells , 2020, Journal of cellular physiology.
[42] C. Ince,et al. Endothelial Responses in Sepsis. , 2020, American journal of respiratory and critical care medicine.
[43] G. Hansmann,et al. Activation of The Metabolic Master Regulator PPARγ - A Potential PIOneering Therapy for Pulmonary Arterial Hypertension. , 2020, American journal of respiratory cell and molecular biology.
[44] É. Azoulay,et al. Immune Consequences of Endothelial Cells' Activation and Dysfunction During Sepsis. , 2020, Critical care clinics.
[45] Yingxian Sun,et al. Role of WW domain E3 ubiquitin protein ligase 2 in modulating ubiquitination and Degradation of Septin4 in oxidative stress endothelial injury , 2020, Redox biology.
[46] Zhongcai Fan,et al. Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes , 2019, Oxidative medicine and cellular longevity.
[47] Lu Lu,et al. Salidroside ameliorates endothelial inflammation and oxidative stress by regulating the AMPK/NF-κB/NLRP3 signaling pathway in AGEs-induced HUVECs. , 2019, European journal of pharmacology.
[48] Xionglei He,et al. A hMTR4‐PDIA3P1‐miR‐125/124‐TRAF6 Regulatory Axis and Its Function in NF kappa B Signaling and Chemoresistance , 2019, Hepatology.
[49] Mohd Hassan Baig,et al. ASK1 and its role in cardiovascular and other disorders: available treatments and future prospects , 2019, Expert review of proteomics.
[50] R. Franke,et al. Vascular Endothelial Cell Biology: An Update , 2019, International journal of molecular sciences.
[51] Bao Hou,et al. Protective Effects and Mechanisms of Vaccarin on Vascular Endothelial Dysfunction in Diabetic Angiopathy , 2019, International journal of molecular sciences.
[52] P. Hordijk,et al. Ubiquitin-based modifications in endothelial cell–cell contact and inflammation , 2019, Journal of Cell Science.
[53] S. Gräf,et al. Molecular genetic framework underlying pulmonary arterial hypertension , 2019, Nature Reviews Cardiology.
[54] M. Fu,et al. TRIM65 E3 ligase targets VCAM-1 degradation to limit LPS-induced lung inflammation , 2019, Journal of molecular cell biology.
[55] Z. Ni,et al. PINK1-parkin pathway of mitophagy protects against contrast-induced acute kidney injury via decreasing mitochondrial ROS and NLRP3 inflammasome activation , 2019, Redox biology.
[56] W. Langdon,et al. Regulation of immune responses by E3 ubiquitin ligase Cbl-b. , 2019, Cellular immunology.
[57] C. Meyer-Schwesinger. The ubiquitin–proteasome system in kidney physiology and disease , 2019, Nature Reviews Nephrology.
[58] Danhui Ma,et al. The PROTAC technology in drug development , 2019, Cell biochemistry and function.
[59] K. Cimprich,et al. PPARγ Interaction with UBR5/ATMIN Promotes DNA Repair to Maintain Endothelial Homeostasis. , 2019, Cell reports.
[60] A. Aerts,et al. Pathological effects of ionizing radiation: endothelial activation and dysfunction , 2018, Cellular and Molecular Life Sciences.
[61] Liang Chen,et al. Relationship between the endothelial glycocalyx and the extent of coronary atherosclerosis , 2018, Microcirculation.
[62] Zhanjun Jia,et al. Parkin Modulates ERRα/eNOS Signaling Pathway in Endothelial Cells , 2018, Cellular Physiology and Biochemistry.
[63] You-yang Zhao,et al. Endothelial and Smooth Muscle Cell Interaction via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension , 2018, American journal of respiratory and critical care medicine.
[64] D. Mcfadden,et al. Disruption of VEGF Mediated Flk‐1 Signaling Leads to a Gradual Loss of Vessel Health and Cardiac Function During Myocardial Infarction: Potential Therapy With Pellino‐1 , 2018, Journal of the American Heart Association.
[65] Tao Wang,et al. TRAF6 mediates high glucose‐induced endothelial dysfunction , 2018, Experimental cell research.
[66] M. Kaur,et al. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies , 2018, Cardiovascular Diabetology.
[67] C. Patterson,et al. Emerging Roles of Vascular Endothelium in Metabolic Homeostasis. , 2018, Circulation research.
[68] X. Tu,et al. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy , 2018, Acta Pharmacologica Sinica.
[69] G. Hu,et al. YAP Controls Endothelial Activation and Vascular Inflammation Through TRAF6 , 2018, Circulation research.
[70] A. Orekhov,et al. Potential of anti-inflammatory agents for treatment of atherosclerosis. , 2018, Experimental and molecular pathology.
[71] D. Geerts,et al. The Cullin-3–Rbx1–KCTD10 complex controls endothelial barrier function via K63 ubiquitination of RhoB , 2018, The Journal of cell biology.
[72] N. Alenina,et al. The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7) , 2017, Physiological reviews.
[73] Jing Zhao,et al. The role of ubiquitination and deubiquitination in the regulation of cell junctions , 2017, Protein & Cell.
[74] B. Zhang,et al. Biomimetic nanoparticles for inflammation targeting , 2017, Acta pharmaceutica Sinica. B.
[75] S. Baek,et al. Trim13 Potentiates Toll-Like Receptor 2–Mediated Nuclear Factor κB Activation via K29-Linked Polyubiquitination of Tumor Necrosis Factor Receptor-Associated Factor 6 , 2017, Molecular Pharmacology.
[76] E. Letsiou,et al. Parkin regulates lipopolysaccharide‐induced proinflammatory responses in acute lung injury , 2017, Translational research : the journal of laboratory and clinical medicine.
[77] A. Malik,et al. Protein Interactions at Endothelial Junctions and Signaling Mechanisms Regulating Endothelial Permeability. , 2017, Circulation research.
[78] C. M. Cadwell,et al. p120-catenin regulates VE-cadherin endocytosis and degradation induced by the Kaposi sarcoma–associated ubiquitin ligase K5 , 2017, Molecular biology of the cell.
[79] M. Murthy,et al. WNK signalling pathways in blood pressure regulation , 2016, Cellular and Molecular Life Sciences.
[80] In-kyu Lee,et al. The endothelial E3 ligase HECW2 promotes endothelial cell junctions by increasing AMOTL1 protein stability via K63-linked ubiquitination. , 2016, Cellular signalling.
[81] L. Treps,et al. The E3 ubiquitin ligase MARCH3 controls the endothelial barrier , 2016, FEBS letters.
[82] M. Balda,et al. Tight junctions: from simple barriers to multifunctional molecular gates , 2016, Nature Reviews Molecular Cell Biology.
[83] L. Kong,et al. Protective effect of trans-δ-viniferin against high glucose-induced oxidative stress in human umbilical vein endothelial cells through the SIRT1 pathway , 2016, Free radical research.
[84] N. Figg,et al. Characterisation of the Cullin-3 mutation that causes a severe form of familial hypertension and hyperkalaemia , 2015, EMBO molecular medicine.
[85] Hao Xu,et al. PINK1-Parkin-Mediated Mitophagy Protects Mitochondrial Integrity and Prevents Metabolic Stress-Induced Endothelial Injury , 2015, PloS one.
[86] M. J. You,et al. MALT1 is required for EGFR induced NF-κB activation and contributes to EGFR-driven lung cancer progression , 2015, Oncogene.
[87] Gautam Sethi,et al. The Vascular Endothelium and Human Diseases , 2013, International journal of biological sciences.
[88] C. Stehouwer,et al. Endothelial dysfunction in (pre)diabetes: Characteristics, causative mechanisms and pathogenic role in type 2 diabetes , 2013, Reviews in Endocrine and Metabolic Disorders.
[89] D. Alessi,et al. The CUL3–KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction , 2013, The Biochemical journal.
[90] R. Schmidt,et al. Genetics of age-related white matter lesions from linkage to genome wide association studies , 2012, Journal of the Neurological Sciences.
[91] Jai Radhakrishnan,et al. Mutations in Kelch-like 3 and Cullin 3 cause hypertension and electrolyte abnormalities , 2012, Nature.
[92] A. Weissman,et al. RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis , 2011, Nature Reviews Cancer.
[93] U. Tepass,et al. Adherens junctions: from molecules to morphogenesis , 2010, Nature Reviews Molecular Cell Biology.
[94] P. Rose,et al. Remodeling of Endothelial Adherens Junctions by Kaposi's Sarcoma-Associated Herpesvirus , 2008, Journal of Virology.
[95] A. Shah,et al. Reactive oxygen species and endothelial activation. , 2008, Antioxidants & redox signaling.
[96] G. Lip,et al. Oxidative stress and hypertension , 2006, International journal of clinical practice.
[97] L. Holmgren,et al. Angiomotin Regulates Endothelial Cell-Cell Junctions and Cell Motility* , 2005, Journal of Biological Chemistry.
[98] David A. Schultz,et al. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress , 2005, Nature.
[99] R. Budhiraja,et al. Endothelial Dysfunction in Pulmonary Hypertension , 2004, Circulation.
[100] M. Crackower,et al. The role of ACE2 in cardiovascular physiology. , 2003, Trends in cardiovascular medicine.
[101] R. Bucala,et al. Advanced glycation end products and endothelial dysfunction in type 2 diabetes. , 2002, Diabetes care.
[102] Paul L Huang,et al. Accelerated Atherosclerosis, Aortic Aneurysm Formation, and Ischemic Heart Disease in Apolipoprotein E/Endothelial Nitric Oxide Synthase Double-Knockout Mice , 2001, Circulation.
[103] R. Busse,et al. Endothelial dysfunction in atherosclerosis. , 1996, Journal of vascular research.
[104] Yutong Zhao,et al. TRIM21 Mitigates Human Lung Microvascular Endothelial Cells ’ In fl ammatory Responses to LPS , 2019 .
[105] R. Touyz,et al. Oxidative Stress, Inflammation, and Vascular Aging in Hypertension , 2017, Hypertension.
[106] P. Libby,et al. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis , 2016 .